BISMUTH SUBSALICYLA

This contract is for the procurement of Bismuth Subsalicylate Suspension, specifically 240 ml bottles with a concentration of 262 mg/15 ml. The order consists of two bottles under NSN 6505-01-505-6483, with a required delivery date of August 13, 2026, and a delivery timeframe of 20 days after order. The product is FDA regulated and must be provided by the Harvard Drug Group, L.L.C. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of this period may have elapsed upon delivery to the government. Packaging must be commercial and sealed to protect contents from damage, adhering to Medical Marking Standard No. 1 and DLA packaging requirements. Delivery is FOB destination to the specified USNS Effective T address.